AI Drug Discovery Platform
Provider 
Founded 2018
Sells To Enterprise
Pricing Model Recurring
Ownership Private equity-backed, Venture-backed

Machine learning platform for drug discovery and development.
Insitro's AI drug discovery platform uses machine learning and data-driven models to identify and develop new therapies.
The platform applies predictive models to disease biology to accelerate therapeutic discovery and development.
Potato

Autonomous Science Agents
readysetpotato.com
1910

Candid-Cns
1910.ai
Mithrl

Mithrl Platform
mithrl.com
| Attribute | AI Drug Discovery Platform | Autonomous Science Agents | Candid-Cns | Mithrl Platform | |
|---|---|---|---|---|---|
| Provider | |||||
| Founded | 2018 | 2023 | 2018 | 2023 | |
| Sells To | Enterprise | Enterprise | Enterprise, Pharmaceutical | Enterprise | |
| Pricing Model | Recurring | Recurring, Software | Licensing | B2B | |
| Ownership | Private equity-backed, Venture-backed | Private, Venture-backed | Venture-backed | Private, Venture-backed |
Provider 
Founded 2018
Sells To Enterprise
Pricing Model Recurring
Ownership Private equity-backed, Venture-backed
Provider 
Founded 2023
Sells To Enterprise
Pricing Model Recurring, Software
Ownership Private, Venture-backed
Provider 
Founded 2018
Sells To Enterprise, Pharmaceutical
Pricing Model Licensing
Ownership Venture-backed
Provider 
Founded 2023
Sells To Enterprise
Pricing Model B2B
Ownership Private, Venture-backed


Pharma.ai is Insilico Medicine's generative AI platform for drug discovery, target identification, and molecule design.

Computational molecular-discovery platform providing in silico prediction of molecular properties including toxicity.


Machine-learning software platform that predicts ADMET and toxicity properties of chemical compounds.


Hybrid Drug Platform combines medicines with adaptive digital treatment protocols.


Isomorphic Labs' Drug Design Engine builds on AlphaFold to predict biomolecular structures for drug discovery.


AI-enabled natural-product drug discovery platform organizing plant chemistry into a searchable library with machine-learning translation and automated screening.


Foundation-model platform for designing sequence-based medicines including siRNA, ASO, mRNA, and peptides.



Compass is Inductive Bio virtual bench platform embedding AI models, lab automation, and chemists in small-molecule discovery.



Allosteric screening and synthetic lethality platforms with 200k library.


Indy is Inductive Bio AI chemistry assistant guiding chemists through design, synthesis, and assay decisions.


Recursion OS is an AI-powered drug discovery and development platform built on massive proprietary biological and chemical datasets.
Pharma.ai is Insilico Medicine's generative AI platform for drug discovery, target identification, and molecule design.

Computational molecular-discovery platform providing in silico prediction of molecular properties including toxicity.

Machine-learning software platform that predicts ADMET and toxicity properties of chemical compounds.

Hybrid Drug Platform combines medicines with adaptive digital treatment protocols.

Isomorphic Labs' Drug Design Engine builds on AlphaFold to predict biomolecular structures for drug discovery.

AI-enabled natural-product drug discovery platform organizing plant chemistry into a searchable library with machine-learning translation and automated screening.

Foundation-model platform for designing sequence-based medicines including siRNA, ASO, mRNA, and peptides.

D360 is a scientific informatics platform that accelerates drug discovery data analysis and collaboration.

Compass is Inductive Bio virtual bench platform embedding AI models, lab automation, and chemists in small-molecule discovery.

Makya is a generative AI platform that designs novel drug-like molecules for medicinal chemistry teams.

Allosteric screening and synthetic lethality platforms with 200k library.

Indy is Inductive Bio AI chemistry assistant guiding chemists through design, synthesis, and assay decisions.

Recursion OS is an AI-powered drug discovery and development platform built on massive proprietary biological and chemical datasets.
